This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
CLS Outpaces Industry in the Past 3 Months: Reason to Buy the Stock?
by Supriyo Bose
CLS surges 24.3% in 3 months, outpacing peers as AI-fueled demand lifts its data center and networking solutions.
Is Most-Watched Stock Celestica, Inc. (CLS) Worth Betting on Now?
by Zacks Equity Research
Celestica (CLS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here's Why Celestica (CLS) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Celestica (CLS) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Celestica (CLS) closed at $116.37, marking a -1.48% move from the previous day.
Why Is Sanmina (SANM) Up 9.6% Since Last Earnings Report?
by Zacks Equity Research
Sanmina (SANM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are Computer and Technology Stocks Lagging Ericsson (ERIC) This Year?
by Zacks Equity Research
Here is how Ericsson (ERIC) and Celestica (CLS) have performed compared to their sector so far this year.
Wall Street Bulls Look Optimistic About Celestica (CLS): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Celestica (CLS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Celestica vs. Plexus: Which EMS Stock is a Better Bet Right Now?
by Aritra Chatterjee
CLS is riding on growing demand for its 400G and 800G switches in AI applications, while PLXS is witnessing strong demand in healthcare and semicap verticals.
If You Invested $1000 in Celestica a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Here is Why Growth Investors Should Buy Celestica (CLS) Now
by Zacks Equity Research
Celestica (CLS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Will Healthy Momentum in IoT and AI Applications Drive NOK Stock?
by Zacks Equity Research
Nokia witnesses solid demand for its 5G Standalone Core and IP routing portfolio for various IoT and AI applications.
Celestica, Inc. (CLS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Celestica (CLS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Wall Street Analysts Think Celestica (CLS) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Celestica (CLS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Here's How Much a $1000 Investment in Celestica Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Looking for a Growth Stock? 3 Reasons Why Celestica (CLS) is a Solid Choice
by Zacks Equity Research
Celestica (CLS) could produce exceptional returns because of its solid growth attributes.
Celestica (CLS) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Celestica (CLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CLS Stock Almost Doubles in a Year: Should You Take the Bait?
by Supriyo Bose
CLS appears primed for further stock price appreciation despite certain short-term headwinds.
Wall Street Analysts Think Celestica (CLS) Could Surge 34.51%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 34.5% in Celestica (CLS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Celestica (CLS) Just Overtook the 50-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Earnings Season: 3 Companies Raising Guidance
by Derek Lewis
Raising guidance? In this uncertainty? These three companies say yes.
Investors Heavily Search Celestica, Inc. (CLS): Here is What You Need to Know
by Zacks Equity Research
Celestica (CLS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Celestica Q1 Earnings Beat Estimates on Solid Revenue Growth
by Zacks Equity Research
CLS reported healthy first-quarter 2025 results driven by stronger growth in the CCS segment.
Celestica (CLS) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Celestica (CLS) delivered earnings and revenue surprises of 8.11% and 3.71%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?